<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2D8E82C0-85D1-4809-90FC-4716F4AF5865"><gtr:id>2D8E82C0-85D1-4809-90FC-4716F4AF5865</gtr:id><gtr:name>Institute of Food Research</gtr:name><gtr:department>Contracts</gtr:department><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:postCode>NR4 7UA</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2D8E82C0-85D1-4809-90FC-4716F4AF5865"><gtr:id>2D8E82C0-85D1-4809-90FC-4716F4AF5865</gtr:id><gtr:name>Institute of Food Research</gtr:name><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:postCode>NR4 7UA</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/052E2A0E-55CE-4D64-A68A-5E5107BC0EAA"><gtr:id>052E2A0E-55CE-4D64-A68A-5E5107BC0EAA</gtr:id><gtr:firstName>Claudio</gtr:firstName><gtr:surname>Nicoletti</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FF%2F00042515"><gtr:id>6474E409-D55A-40D8-9210-9312451F36C9</gtr:id><gtr:title>Towards Safe and Effective Immunotherapy of Persistent Life-Threatening Food Allergies</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/F/00042515</gtr:grantReference><gtr:abstractText>This collaborative project brings together clinicians, immunologists and biochemists from 15 centres, including 4 industrial partners, to develop specific immunotherapy for food allergy. This approach currently offers the only opportunity to provide food allergic individuals with a cure. The study is focussed on two foods, fish and peach and will develop hypoallergenic mutants of the major allergens in these foods, namely fish parvalbumin and peach lipid transfer protein (LTP). The mutants will be produced either by heterologous expression and initially their efficacy for immunotherapy will be assessed using animal models. Mutants that pass this initial phase will then enter into clinical studies to evaluate their efficacy in man. IFR is involved in the initial stages with Dr Clare Mills evaluating the hypoallergenic variants from a structural view point whilst Professor Claudio Nicoletti is undertaking animal model studies to assess the efficacy of the peach LTP mutants.</gtr:abstractText><gtr:fund><gtr:end>2015-08-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-09-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>178600</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>our findings will be used to develop specific immunotherapy of food allergy</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>96466AB1-A0A9-41B0-A05F-050F5C95B27B</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>546326e3919b09.99285579</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Hypoallergenic protein have been used in the treatment of individuals affected by food allergy</gtr:description><gtr:exploitationPathways>use this work to treat allergy to fish allergen</gtr:exploitationPathways><gtr:id>A6F8E3B1-90E5-4BD4-9955-D7705216D1F0</gtr:id><gtr:outcomeId>5463267f26ec59.23095324</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:sectors><gtr:url>http://www.google.co.uk/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=6&amp;ved=0ahUKEwjgqLeM4pzLAhUBExQKHSHEC60QFgg-MAU&amp;url=http%3A%2F%2Fwww.ctajournal.com%2Fsupplements%2Ffull%2F2045-7022-3-S3.pdf&amp;usg=AFQjCNFKc5fe_fMt1LwMbaKL77IWEPrd-g</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0D5A82C4-EFEF-4315-A318-DF555B7A1B8C</gtr:id><gtr:title>FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies.</gtr:title><gtr:parentPublicationTitle>Clinical and translational allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f7fcf32ef7e65d1ffc16dfc0408f4f3"><gtr:id>4f7fcf32ef7e65d1ffc16dfc0408f4f3</gtr:id><gtr:otherNames>Zuidmeer-Jongejan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2045-7022</gtr:issn><gtr:outcomeId>5460e6b0ca16e5.52101382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BF27873-43EC-4230-B349-2B3E7DCD7BA9</gtr:id><gtr:title>Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy.</gtr:title><gtr:parentPublicationTitle>International archives of allergy and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f7fcf32ef7e65d1ffc16dfc0408f4f3"><gtr:id>4f7fcf32ef7e65d1ffc16dfc0408f4f3</gtr:id><gtr:otherNames>Zuidmeer-Jongejan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1018-2438</gtr:issn><gtr:outcomeId>56d41eb9438254.91082289</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/F/00042515</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>